Glaxo Shareholders Grumble Over Viehbacher’s Retention Bonus

Chris Viehbacher’s consolation prize for losing GlaxoSmithKline’s CEO horse race was a stock bonus worth somewhere between $4 million and $5 million. More than a third of shareholders who voted on that retention package this week refused to endorse it. The Financial Times calls that “a strong protest,” given that shareholder votes tend to rubber [...]